NAT, by directly detecting viral RNA, can reduce the window period to approximately 7-11 days post-infection, thereby significantly enhancing blood safety.6 However, NAT is associated with drawbacks such as high cost, operational complexity, and stringent laboratory infrastructure requirements. Here, BRD2 is linked to infection.